Global Rheumatoid Arthritis Drugs Markets 2018-2022 Featuring Abbvie, Amgen, Bristol-Myers Squibb , F. Hoffmann-La Roche & Pfizer
Global Rheumatoid Arthritis Drugs Markets 2018-2022 Featuring Abbvie, Amgen, Bristol-Myers Squibb , F. Hoffmann-La Roche & Pfizer
DUBLIN, March 21, 2018 /PRNewswire/ --
The "Drugs for Rheumatoid Arthritis: Global Markets to 2022" report has been added to ResearchAndMarkets.com's offering.
http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
This research report categorizes the drugs for rheumatoid arthritis market by type. Product type include disease modifying anti-rheumatic drugs, non-steroidal anti-inflammatory drugs and corticosteroids.
Report Includes:
-- 95 data tables -- An overview of the global rheumatoid arthritis drugs market -- Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022 -- Identification of segments with high growth potential and their future applications -- Explanation of major drivers and regional dynamics of the market and current trends within the industry
Key Topics Covered:
1 Introduction
2 Summary and Highlights
3 Drugs for Rheumatoid Arthritis Market Characteristics
4 Drugs for Rheumatoid Arthritis Market Size and Growth
-- Historic Market Growth -- Drivers of the Market -- Restraints on the Market -- Forecast Market Growth -- Drivers of the Market -- Restraints on the Market
5 Drugs for Rheumatoid Arthritis Market Trends and Strategies
-- Increasing Use of Technology -- 3D Printing Technologies -- Combo and Mono Therapy -- New Applications of NSAIDS
6 PESTLE Analysis
-- Political -- Government Financial Support -- Uncertain Political Policies -- Economic -- Wealth -- Globalization -- Emerging Markets -- Social -- Ageing Global Population -- Sedentary Lifestyles -- Health Consciousness and Awareness -- Traditional Medicine Continues to Pose Threat to Market -- Technological -- 3D Printing Technologies -- Internet Penetration and Mobile Applications -- Legal -- Stringent Regulations and Long Approval Procedures -- Investment Regulations -- Patent Issues -- Government Intervention -- Environmental
7 Drugs for Rheumatoid Arthritis Market Segmentation
-- Global Drugs for Rheumatoid Arthritis Market, By Segment -- Global Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022 -- Disease Modifying Anti-Rheumatic Drugs (DMARDs) -- Market Characteristics -- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) -- Market Characteristics -- Corticosteroids -- Market Characteristics
8 Drugs for Rheumatoid Arthritis Market Regional and Country Analysis
-- Global Drugs for Rheumatoid Arthritis Market, By Region -- Global Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Region -- Global Drugs for Rheumatoid Arthritis Market Segmentation, By Region, 2017 -- Global Drugs for Rheumatoid Arthritis Market, By Country -- Global Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Country -- Global Drugs for Rheumatoid Arthritis Market Segmentation, 2017, By Country
9 Global Drugs for Rheumatoid Arthritis Market Comparison with Macro Economic Factors
-- Global Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure -- Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure, By Country
10 Asia-Pacific Drugs for Rheumatoid Arthritis Market
11 Asia-Pacific Drugs for Rheumatoid Arthritis Market: Country Analysis
12 Western Europe Drugs for Rheumatoid Arthritis Market
13 Western Europe Drugs for Rheumatoid Arthritis Market: Country Analysis
14 Eastern Europe Drugs for Rheumatoid Arthritis Market
15 Eastern Europe Drugs for Rheumatoid Arthritis Market: Country Analysis
16 North America Drugs for Rheumatoid Arthritis Market
17 North America Drugs for Rheumatoid Arthritis Market: Country Analysis18 South America Drugs for Rheumatoid Arthritis Market
19 South America Drugs for Rheumatoid Arthritis Market: Country Analysis
20 Middle East Drugs for Rheumatoid Arthritis Market
21 Africa Drugs for Rheumatoid Arthritis Market
22 Drugs for Rheumatoid Arthritis Market Customer Information
-- Frequency of Pain after Treatment -- Different Symptoms Experienced by Patients -- Impact of Rheumatoid Arthritis at Workplace -- Importance of Patient's Role in the Management of Rheumatoid Arthritis -- Capacity of Affordable Treatment
23 Drugs for Rheumatoid Arthritis Market Competitive Landscape
-- Company Profiles -- Abbvie Inc. -- Amgen Inc. -- Bristol-Myers Squibb Company -- F. Hoffmann-La Roche AG -- Pfizer
24 Key Mergers and Acquisitions in the Drugs for Rheumatoid Arthritis Market
-- Pfizer Acquired Hospira -- Concordia Healthcare Acquired Covis Pharma Commercial Assets -- Bristol-Myers Squibb Acquired Padlock Therapeutics -- Alvotech Acquired Baliopharm -- Atnahs Acquired Pharmaceutical Assets of F. Hoffmann-La Roche
25 Appendix
Companies Mentioned
-- AbbVie Inc. -- Amgen Inc. -- Biogen -- Merck & Co. -- Bristol-Myers Squibb -- Hoffmann-La Roche -- Johnson & Johnson -- Mitsubishi Tanabe Pharma Corporation -- Pfizer -- UCB S.A.
For more information about this report visit https://www.researchandmarkets.com/research/qd8s65/global_rheumatoid?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/global-rheumatoid-arthritis-drugs-markets-2018-2022-featuring-abbvie-amgen-bristol-myers-squibb--f-hoffmann-la-roche--pfizer-300617394.html
SOURCE Research and Markets